By
University of North Carolina Health Care
Published: Aug. 8, 2022, 3:34 p.m.·
Tags:
Treatment
Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin.
Read More →